Ligand · 227
227 · 6,7-dimethoxy-4-{8-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydroisoquinolin-2(1H)-yl}quinazoline
227, 6,7-dimethoxy-4-{8-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydroisoquinolin-2(1H)-yl}quinazoline (C24 H29 N5 O4 S, 483.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- 227
- Formula
- C24 H29 N5 O4 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
227 in 2 structures; the first of them:
- 2O8H · Crystal structure of the catalytic domain of rat phosphodiesterase 10A · 227 A999 · binds LEU625, PHE629, LEU665, SER667, VAL668, ILE682, TYR683, PHE686 and 7 more
- 2O8H · Crystal structure of the catalytic domain of rat phosphodiesterase 10A · 227 A999 · binds LEU625, PHE629, LEU665, SER667, VAL668, ILE682, TYR683, PHE686 and 7 more
Residues it binds most
PHE 2, GLY 2, LEU 2, VAL 2, ALA 2, GLN 2, ILE 2, MET 2, SER 2, TYR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.